CHST11 and hepatocellular carcinoma: Furthermore, data from the Kaplan–Meier plotter validated that HCC patients with higher expression level of CHST11 showed shorter overall survival (HR = 1.76, 95% CI = 1.23–2.52, p = 0.0016; Figure 2F) as well as disease‐specific survival (HR = 1.65, 95% CI = 1.03–2.63, p = 0.034; Figure 2G).